Search Results - "Debouverie, M."

Gender as a prognostic factor and its impact on the incidence of multiple sclerosis in Lorraine, France by Debouverie, M

“…Abstract We sought to identify (a) the change of incidence rates among gender from 1990 to 2002 from the LORSEP (Lorraine Multiple Sclerosis) population-based…”
Get full text

Serology results after COVID vaccine in multiple sclerosis patients treated with fingolimod by Ciccone, A., Mathey, G., Prunis, C., Debouverie, M.

“…While it is recommended that patients with multiple sclerosis (MS) be vaccinated against COVID-19, it is unknown what the vaccine response is in MS patients…”
Get full text

Natural history of multiple sclerosis in a population-based cohort by Debouverie, M., Pittion-Vouyovitch, S., Louis, S., Guillemin, F.

“…Background and purpose:  We sought to identify predictive clinical factors of disability during initial course in multiple sclerosis (MS) patients. Methods:  A…”
Get full text

Modafinil for fatigue in MS : A randomized placebo-controlled double-blind study by STANKOFF, B, WAUBANT, E, CONFAVREUX, C, EDAN, G, DEBOUVERIE, M, RUMBACH, L, MOREAU, T, PELLETIER, J, LUBETZKI, C, CLANET, M

“…To assess whether modafinil, a wakefulness-promoting agent, is useful for fatigue in patients with multiple sclerosis (MS). Patients with MS with stable…”
Get full text

Fatigue in multiple sclerosis is related to disability, depression and quality of life by Pittion-Vouyovitch, S., Debouverie, M., Guillemin, F., Vandenberghe, N., Anxionnat, R., Vespignani, H.

“…Fatigue in multiple sclerosis is a frequent and disabling symptom that can interfere in daily functioning. The aim of this study is to demonstrate the…”
Get full text

A decade of fingolimod in multiple sclerosis: Insights from a large real-world cohort study by Gauer, L., Bigaut, K., Berger, É., Debouverie, M., Moreau, T., de Sèze, J.

“…•Annualized relapse rate stays low after several years of fingolimod treatment.•Relapse risk depends on the number of relapses preceding fingolimod initiation,…”
Get full text

Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile by Lebrun, C, Bensa, C, Debouverie, M, De Seze, J, Wiertlievski, S, Brochet, B, Clavelou, P, Brassat, D, Labauge, P, Roullet, E

“…The concept of preclinical multiple sclerosis is now well recognised, and a diagnosis of silent brain T2 lesions is frequent because of the ease of performing…”
Get full text

Cognitive impairment in glycogen storage disease type III with severe heart failure: A case report by Michaud, M., Dillier, C., Selton, M., Michot, N., Metzdorf, A., Debouverie, M.

Get full text

Clinical follow‐up of 411 patients with relapsing and progressive multiple sclerosis 10 years after discontinuing mitoxantrone treatment: a real‐life cohort study by Chartier, N., Epstein, J., Soudant, M., Dahan, C., Michaud, M., Pittion‐Vouyovitch, S., Guillemin, F., Debouverie, M., Mathey, G.

“…Background and purpose Mitoxantrone (MITOX) has been used to treat patients with aggressive multiple sclerosis (MS) for decades. We aimed to describe the…”
Get full text

Classification and diagnostic criteria for demyelinating diseases of the central nervous system: Where do we stand today? by Mathey, G., Michaud, M., Pittion-Vouyovitch, S., Debouverie, M.

“…The diagnosis of multiple sclerosis (MS) and other demyelinating diseases of the central nervous system is challenging, and although the currently available…”
Get full text

Developing tools to evaluate quality of care management for patients living with multiple sclerosis: An original French initiative by Veillard, D., Deburghgraeve, V., Le Page, E., Debouverie, M., Wiertlewski, S., Gallien, P., Edan, G.

“…Assessing the quality of care management for patients with a chronic disease such as multiple sclerosis (MS) is a major challenge for healthcare systems around…”
Get full text

Neuromyelitis optica in France: A multicenter study of 125 patients by COLLONGUES, N, MARIGNIER, R, FONTAINE, B, BRASSAT, D, CLANET, M, MILH, M, PELLETIER, J, AUDOIN, B, RUET, A, LEBRUN-FRENAY, C, THOUVENOT, E, CAMU, W, ZEPHIR, H, DEBOUVERIE, M, CREANGE, A, MOREAU, T, LABAUGE, P, CASTELNOVO, G, EDAN, G, LE PAGE, E, DEFER, G, BARROSO, B, HEINZLEF, O, PAPEIX, C, GOUT, O, RODRIGUEZ, D, WIERTLEWSKI, S, LAPLAUD, D, BORGEL, F, TOURNIAIRE, P, GRIMAUD, J, BROCHET, B, VERMERSCH, P, CONFAVREUX, C, BLANC, F, DE SEZE, J, RITLENG, C, TCHIKVILADZE, M, OUTTERYCK, O, VUKUSIC, S, FLEURY, M

“…There have been few epidemiologic studies on neuromyelitis optica (NMO) and none used the recent 2006 diagnostic criteria. Here we describe the clinical,…”
Get full text

Dronabinol use in France between 2004 and 2017 by Lejczak, S., Rousselot, H., Di Patrizio, P., Debouverie, M.

“…To investigate prescription practices for dronabinol, a pure extract of delta-9-tetrahydrocannabinol, prescribed for refractory chronic pain in France since…”
Get full text

Validity of a French version of the fatigue impact scale in multiple sclerosis by Debouverie, M., Pittion-Vouyovitch, S., Louis, S., Guillemin, F.

“…Purpose Fatigue is a frequent and common symptom of multiple sclerosis (MS) that can interfere with patients' everyday activities. There is no objective scale…”
Get full text

Evaluation of the quality of the care pathway for patients with multiple sclerosis in France: Results of an original study of a cohort of 700 patients by Veillard, D., Le Page, E., Epstein, J., Wiertlewski, S., Gallien, P., Hamonic, S., Debouverie, M., Edan, G.

“…Evaluating the quality of the care pathway for patients with chronic diseases, such as multiple sclerosis (MS), is an important issue. Process indicators are a…”
Get full text

Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study by Siri, A., Carra-Dalliere, Clarisse, Ayrignac, X., Pelletier, J., Audoin, B., Pittion-Vouyovitch, S., Debouverie, M., Lionnet, C., Viala, F., Sablot, D., Brassat, D., Ouallet, J.-C., Ruet, A., Brochet, B., Taillandier, L., Bauchet, L., Derache, N., Defer, G., Cabre, P., de Seze, J., Lebrun Frenay, C., Cohen, M., Labauge, P.

“…Isolated tumefactive demyelinating lesion (TDL) is a rare disease and a challenging entity especially for the differential diagnosis, biopsy indications, and…”
Get full text

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis by Lefort, M, Sharmin, S, Andersen, J B, Vukusic, S, Casey, R, Debouverie, M, Edan, G, Ciron, J, Ruet, A, De Sèze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanché, J P, Maurousset, A, Ben Nasr, H, Hankiewicz, K, Pottier, C, Maubeuge, N, Dimitri-Boulos, D, Nifle, C, Laplaud, D A, Horakova, D, Havrdova, E K, Alroughani, R, Izquierdo, G, Eichau, S, Ozakbas, S, Patti, F, Onofrj, M, Lugaresi, A, Terzi, M, Grammond, P, Grand'Maison, F, Yamout, B, Prat, A, Girard, M, Duquette, P, Boz, C, Trojano, M, McCombe, P, Slee, M, Lechner-Scott, J, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Shaygannejad, V, Prevost, J, Maimone, D, Skibina, O, Buzzard, K, Van der Walt, A, Karabudak, R, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Koch-Henriksen, N, Sellebjerg, F, Soerensen, P S, Hilt Christensen, C C, Rasmussen, P V, Jensen, M B, Frederiksen, J L, Bramow, S, Mathiesen, H K, Schreiber, K I, Butzkueven, H, Magyari, M, Kalincik, T, Leray, E

“…Natalizumab and fingolimod are used as high-efficacy treatments in relapsing-remitting multiple sclerosis. Several observational studies comparing these two…”
Get full text

Verbal episodic memory in 426 multiple sclerosis patients: impairment in encoding, retrieval or both? by Brissart, H., Morele, E., Baumann, C., Debouverie, M.

“…Episodic memory is frequently impaired in multiple sclerosis (MS) patients but the exact nature of the disorder is controversial. It was initially thought to…”
Get full text

Cognitive rehabilitation in Multiple sclerosis by Brissart, H., Leroy, M., Morele, E., Baumann, C., Spitz, E., Debouverie, M.

“…Cognitive impairments are frequent in Multiple sclerosis (MS). However, most studies about efficacy of cognitive rehabilitation interventions have been…”
Get full text

Is it always useful to perform lumbar puncture for the diagnosis of multiple sclerosis? Yes by Debouverie, M

Get full text